Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Cancer-induced bone pain (CIBP) represents a formidable clinical challenge with complex mechanisms, and existing treatments remain unable to effectively control pain in many patients. This study combined bibliometric and bioinformatic approaches to delineate key research trends, principal themes and future directions in the field of bone metastasis and pain research over the past decade (2015-2024).

Methods: We selected 1,822 relevant documents from the Web of Science Core Collection for bibliometric analysis to identify major research characteristics, collaboration networks and emerging trends. Additionally, we employed bioinformatic methods to screen core genes associated with both bone metastasis and cancer pain, and analysed their functions and signalling pathways.

Results: Research output and academic influence demonstrated an upward trajectory, with the United States and China being the countries with the highest publication volumes. Research hotspots are shifting from traditional palliative treatments towards precision therapies, with stereotactic body radiotherapy, minimally invasive ablation techniques and neuropathic pain mechanisms representing major research frontiers. Bioinformatic analysis identified core hub genes such as TP53 and EGFR, and revealed significant enrichment of signalling pathways including PI3K-Akt, MAPK and TNF in the common pathological processes of bone metastasis and pain.

Conclusion: This study, for the first time combining both methodologies, revealed the field's evolution from traditional treatments towards precision interventions and mechanistic exploration. The molecular targets and signalling pathways we identified provide promising directions for developing novel therapies capable of simultaneously controlling tumour progression and alleviating pain.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12378528PMC
http://dx.doi.org/10.3389/fmed.2025.1619607DOI Listing

Publication Analysis

Top Keywords

bone metastasis
16
metastasis pain
8
treatments precision
8
signalling pathways
8
pain
7
bone
5
pain dual
4
dual lens
4
lens bibliometrics
4
bibliometrics bioinformatics
4

Similar Publications

Background: Lung cancer brain metastasis (LCBM) accounts for 40-50% of intracranial malignancies, with emerging evidence of alternative metastatic pathways circumventing the blood-brain barrier. Existing prognostic models lack validation in Asian populations and molecular stratification. This multicenter study aimed to develop a clinical nomogram integrating clinicopathological and molecular determinants for personalized LCBM management.

View Article and Find Full Text PDF

Mast cell tumors (MCTs) are the most common skin neoplasms in dogs and exhibit highly variable biological behavior. Metastasis primarily affects the lymph nodes, though less frequently, MCTs can infiltrate the spleen, liver, peripheral blood, and bone marrow. Flow cytometry of fine needle aspirate samples represents a non-invasive diagnostic procedure that has shown promise for detecting and quantifying mast cells in primary tumors and lymph nodes.

View Article and Find Full Text PDF

Lung cancer is the leading cause of cancer and cancer-related deaths, and India ranks the fourth highest country. Lung cancer is a highly aggressive malignancy with a tendency for rapid progression, making early detection and prompt treatment essential for improving patient outcomes. Lung cancer can spread locally into surrounding tissue as well as travel through lymphatics to other parts of the body, most often to bone, brain, liver, and adrenal glands.

View Article and Find Full Text PDF

Evaluating the Oncologic and Safety Outcomes of High-Dose Palliative Radiation Treatment with 30 Grays in Five Fractions.

Cureus

August 2025

Division of Radiation Oncology and Developmental Radiotherapeutics, BC Cancer - Vancouver, Vancouver, CAN.

Introduction In select tumor sites, symptom palliation and local control can be improved through delivering higher biological equivalent doses (BED) of radiotherapy. However, not all patients are suitable candidates for stereotactic body radiation therapy (SBRT). The 30 Grays in five fractions (30/5) regimen is a conformal, hypofractionated regimen that offers a higher BED compared to conventional palliative radiotherapy.

View Article and Find Full Text PDF

High Levels of Systemic Inflammatory Markers Associated with Metastasis Incidence in Osteosarcoma.

Rev Bras Ortop (Sao Paulo)

June 2025

Department of Orthopedics and Traumatology, Faculty of Medicine, Udayana University, Prof. Ngoerah General Hospital, Bali, Indonesia.

Objective: The present study explores the association between these inflammatory markers and metastasis in osteosarcoma patients.

Methods: We conducted a retrospective analysis of osteosarcoma patients at our center between January 2022 and August 2024. We collected the clinical and laboratory data of the patients, including white blood cell differential count, C-reactive protein (CRP) levels, erythrocyte sedimentation rate (ESR), neutrophil-to-lymphocyte ratio (NLR), alkaline phosphatase (ALP) and lactate dehydrogenase (LDH) levels.

View Article and Find Full Text PDF